IP Verse

Lava Therapeutics N.v. opposition analysis

COMPANY ANALYSIS

Patent Number:

Title:

Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of Cancer

Applicant:

Opposition Date:

Nov 17, 2021

Patent Number	Title	Applicant	Opposition Date
EP3177645	Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of Cancer	LINDHOFER, HORST, DR.	Nov 17, 2021

LINDHOFER, HORST, DR.

LINDIS BIOTECH GMBH

LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN

Feel free to send us a message here and we will get back to you